Isoform-specific upregulation of palladin in human and murine pancreas tumors

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Goicoechea, Silvia M ^a   Bednarski, Brian ^a,b   Stack, Christianna ^a   Cowan, David W ^a   Volmar, Keith ^b   Thorne, Leigh ^a,b   Cukierman, Edna ^c   Rustgi, Anil K ^d   Brentnall, Teresa ^e   Hwang, Rosa F ^f   McCulloch, Christopher A G ^g   Yeh, Jen Jen ^a,b   Bentrem, David J ^h   Hochwald, Steven N ⁱ   Hingorani, Sunil R ^j   Kim, Hong Jin ^a,b   Otey, Carol A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF FLORIDA   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; ISOPROTEIN; MONOCLONAL ANTIBODY; PALLADIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA; PALLADIN PROTEIN, HUMAN; PALLADIN PROTEIN, MOUSE; PHOSPHOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL TYPE; CONTROLLED STUDY; EARLY DIAGNOSIS; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIMARY TUMOR; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; GENETICS; IMMUNOASSAY; MUTATION; PANCREAS CARCINOMA; PATHOLOGY;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CYTOSKELETAL PROTEINS; FIBROBLASTS; HUMANS; IMMUNOASSAY; MICE; MUTATION; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77956403880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010347     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, et al. (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198: 722-731.
3. Conlon KC, Klimstra DS, Brennan MF (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5- year survivors. Ann Surg 223: 273-279.
4. Sebolt-Leopold JS, English JM (2006) Mechanisms of drug inhibition of signalling molecules. Nature 441: 457-462.
5. Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, et al. (2006) Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med 3: e516.
6. Salaria SN, Illei P, Sharma R, Walter KM, Klein AP, et al. (2007) Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells. Cancer Biol Ther 6: 324-328.
7. Goicoechea S, Arneman D, Disanza A, Garcia-Mata R, Scita G, et al. (2006) Palladin binds to Eps8 and enhances the formation of dorsal ruffles and podosomes in vascular smooth muscle cells. J Cell Sci 119: 3316-3324.
8. Goicoechea SM, Arneman D, Otey CA (2008) The role of palladin in actin organization and cell motility. Eur J Cell Biol 87: 517-525.
9. Jin L, Yoshida T, Ho R, Owens GK, Somlyo AV. (2008) The actin associated protein palladin is required for development of normal contractile properties of smooth muscle cells derived from embryoid bodies. J Biol Chem.
10. Parast MM, Otey CA (2000) Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J Cell Biol 150: 643-656.
11. Boukhelifa M, Hwang SJ, Valtschanoff JG, Meeker RB, Rustioni A, et al. (2003) A critical role for palladin in astrocyte morphology and response to injury. Mol Cell Neurosci 23: 661-668.
12. Jin L, Kern MJ, Otey CA, Wamhoff BR, Somlyo AV (2007) Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration. Circ Res 100: 817-825.
13. Ronty MJ, Leivonen SK, Hinz B, Rachlin A, Otey CA, et al. (2006) Isoformspecific regulation of the actin-organizing protein palladin during TGF-beta1- induced myofibroblast differentiation. J Invest Dermatol 126: 2387-2396.
14. Luo H, Liu X, Wang F, Huang Q, Shen S, et al. (2005) Disruption of paladin results in neural tube closure defects in mice. Mol Cell Neurosci 29: 507-515.
15. Goicoechea SM, Bednarski B, Garcia-Mata R, Prentice-Dunn H, Kim HJ, et al. (2008) Palladin contributes to invasive motility in human breast cancer cells. Oncogene 28: 587-98.
16. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, et al. (2004) Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64: 8585-8594.
17. Mykkanen OM, Gronholm M, Ronty M, Lalowski M, Salmikangas P, et al. (2001) Characterization of human palladin, a microfilament-associated protein. Mol Biol Cell 12: 3060-3073.
18. Rachlin AS, Otey CA (2006) Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin. J Cell Sci 119: 995-1004.
19. Wang HV, Moser M (2008) Comparative expression analysis of the murine palladin isoforms. Dev Dyn 237: 3342-3351.
20. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926.
21. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, et al. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7: 469-483.
22. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450.
23. Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A, et al. (2007) Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 11: 229-243.
24. Tuveson DA, Hingorani SR (2005) Ductal pancreatic cancer in humans and mice. Cold Spring Harb Symp Quant Biol 70: 65-72.
25. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
26. Mahadevan D, Von Hoff DD (2007) Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 6: 1186-1197.
27. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, et al. (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9: 1392-1400.
28. Endlich N, Schordan E, Cohen CD, Kretzler M, Lewko B, et al. (2009) Palladin is a dynamic actin-associated protein in podocytes. Kidney Int 75: 214-226.
29. Liu XS, Luo HJ, Yang H, Wang L, Kong H, et al. (2007) Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing beta1-integrin. J Cell Biochem 100: 1288-1300.
30. Paszek MJ, Weaver VM (2004) The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia 9: 325-342.
31. Rozen P, Liphshitz I, Rosner G, Barchana M, Lachter J, et al. Pancreatic Cancer Consortium (2009) Pancreatic cancer in Israel: the epidemiology, possibilities of prevention, early detection and screening. Isr Med Assoc J. 11(12): 710-713.
32. Arora PD, Janmey PA, McCulloch CA (1999) A role for gelsolin in stress fiberdependent cell contraction. Exp Cell Res 250: 155-167.
33. McCulloch CA, Knowles GC (1993) Deficiencies in collagen phagocytosis by human fibroblasts in vitro: a mechanism for fibrosis? J Cell Physiol 155: 461-471.
34. Corsino P, Davis B, Law M, Chytil A, Forrester E, et al. (2007) Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Cancer Res 67: 3135-3144.